Loading the player… The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In this March 25, 2021 file photo, a box of the Johnson & Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. (AP Photo/Ted… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Questions Advertisement Continue reading the main story Supported by Continue reading the main story AstraZeneca Vaccine and Blood Clots: What Is Known So Far In rare cases, an immune reaction has led to antibodies that caused a serious clotting… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Rollout Advertisement Continue reading the main story Supported by Continue reading the main story The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents A clinical trial found no infections among vaccinated children ages 12 to 15, the… Read More »
A coronavirus vaccine developed by AstraZeneca and the University of Oxford was strongly protective against COVID-19 in the partners’ largest study yet, a significant finding for a shot that has been mired in controversy but could still play a crucial role. The result, which comes from a Phase 3 trial of 32,449 participants in the… Read More »
Read the Full Article for Free! Read the Full Article for Free! Daily Newsletter Weekly Newsletter (Every Monday) You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that… Read More »
Prof Martin Marshall, chair of the Royal College of GPs, said: “The focus for GPs and our teams is currently to offer vaccinations to patients from group six… this is a large group of approximately seven million patients, and it is likely some patients in this group will not yet have been invited for their… Read More »
The Oxford-AstraZeneca and Pfizer-BioNTech vaccines appear to be exceeding even the most optimistic expectations. New data released by Public Health England (PHE) shows that a single shot of either vaccine reduces the chance of needing hospital treatment by more than 80 percent. For most people, getting a jab will cause only mild and short-lived side… Read More »